Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation?
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference89 articles.
1. Adjuvant aminoglutethimide for postmenopausal patients with primary breast cancer: Analysis at 8 years;Jones;J Clin Oncol,1992
2. Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: Results of an Italian cooperative study;Boccardo;J Clin Oncol,2001
3. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer Preliminary results of the Italian Tamoxifen Anastrozole trial;Boccardo;J Clin Oncol,2005
4. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial;Forbes;Lancet Oncol,2008
5. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer;Thurlimann;N Engl J Med,2005
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence;Advances in Therapy;2022-01-06
2. Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin;Breast Cancer Research and Treatment;2021-09-23
3. Effects of PI3K inhibition in AI-resistant breast cancer cell lines: autophagy, apoptosis, and cell cycle progression;Breast Cancer Research and Treatment;2021-09-08
4. Estrogen Receptor Modulators;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26
5. Leptin-elicited PBX3 confers letrozole resistance in breast cancer;Endocrine-Related Cancer;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3